{"cursor":"5196","size":15,"audio":[],"currentlang":"en","article":"{{multiple issues|\n\n\n\n}} A 'drug of last resort' is a common name for a pharmaceutical agent that is\ntried after all other treatment options have failed to produce adequate response\nin the patient. Such an alternative may be outside of extant regulatory\nrequirements or medical best practices. It can also refer to situations in which\nonly a single known medication exists to treat a particular condition.\n\nThe use of a drug of last resort may be based on agreement among members of a\npatient's care network, including physicians and healthcare professionals across\nmultiple specialities, or on a patient's desire to pursue a particular course of\ntreatment and a practitioner's willingness to administer that course. Certain\nsituations such as severe bacterial related sepsis / septic shock can more\ncommonly lead to situations in which a drug of last resort is used.\n\nTherapies considered to be drugs of last resort may at times be used earlier due\nto severity or indication of an agent likely to show the most immediate dose-\nresponse related efficacy in time-critical situations (high mortality\ncircumstances). Many of the drugs considered to be of last resort fall into one\nor more of the categories of antibiotics, antivirals, and chemotherapy agents.\nThese agents often exhibit what are considered to be among the most efficient\ndose-response related antibiotic, antiviral, or anticancer effects, or are drugs\nfor which few or no resistant strains are known.\n\nWith regard to antibiotics, antivirals, and other agents indicated for treatment\nof infectious pathological disease, drugs of last resort are commonly withheld\nfrom administration until after the trial and failure of more commonly used\ntreatment options to prevent the development of resistance. One of the most\ncommonly known examples of both antimicrobial resistance and the relationship to\nthe classification of a drug of last resort is the emergence of methicillin-\nresistant Staphylococcus aureus MRSA (sometimes also referred to as multiple-\ndrug resistant S. aureus due to resistance to non-penicillin antibiotics that\nsome strains of S. aureus have shown to exhibit). In cases presenting with\nsuspected S. aureus, it is suggested by many public health institutions\n(including the World Health Organization (WHO) and the Centers for Disease\nControl and Prevention (CDC) in the United States) to treat first with empirical\ntherapies for S. aureus, with an emphasis on evaluating the response to initial\ntreatment and laboratory diagnostic techniques to isolate cases of drug\nresistance.\n\nDue to the possibility of potential severe or fatal consequences of resistant\nstrains, initial treatment often includes concomitant administration of multiple\nantimicrobial agents that are not known to show cross-resistance, to reduce the\npossibility of a resistant strain remaining inadequately treated by a single\nagent during the evaluation of drug response. Once a specific resistance profile\nhas been isolated via clinical laboratory findings, treatment is often modified\nas indicated.\n\nVancomycin has long been considered a drug of last resort, due to its efficiency\nin treating multiple drug-resistant infectious agents and the requirement for\nintravenous administration. Recently, resistance to even vancomycin has been\nshown in some strains of S. aureus (sometimes referred to as vancomycin\nresistant S. aureus or vancomycin intermediate-resistance S. aureus (VRSA or\nVISA) often coinciding with methicillin/penicillin resistance, prompting the\ninclusion of newer antibiotics (such as linezolid) that have shown efficacy in\nhighly drug-resistant strains.\n\nAgents classified as fourth-line (or greater) treatments or experimental\ntherapies could be considered by default to be drugs of last resort due to their\nlow placement in the treatment hierarchy. Such placement may result from a\nmultitude of considerations, including: greater efficacy of other agents,\nsocioeconomic considerations, availability issues, unpleasant side effects or\nsimilar issues relating to patient tolerance. Some experimental therapies might\nalso be called drugs of last resort when administered following the failure of\nall known and currently accepted treatments.\n\nDespite the fact that most of the notable drugs of last resort are antibiotics\nor antivirals, other drugs are sometimes considered drugs of last resort, such\nas cisapride.\n","linknr":137,"url":"Drug_of_last_resort","recorded":1376419480,"links":["/w/index.php?title=Drug_of_last_resort&action=edit","/w/index.php?title=Drug_of_last_resort&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Drug_of_last_resort","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//en.wikipedia.org/w/index.php?title=Drug_of_last_resort&action=edit","/wiki/Talk:Drug_of_last_resort","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:WikiProject_Pharmacology","/wiki/Wikipedia:P","//upload.wikimedia.org/wikipedia/commons/thumb/5/52/Acap.svg/36px-Acap.svg.png","/wiki/Wikipedia:Basic_copyediting","//en.wikipedia.org/w/index.php?title=Drug_of_last_resort&action=edit","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:Avoid_weasel_words","/wiki/Wikipedia:Neutral_point_of_view","/wiki/Wikipedia:Verifiability","/wiki/Wikipedia:Avoid_weasel_words#Improving_weasel-worded_statements","/wiki/Sepsis","/wiki/Septic_shock","/wiki/Dose-response_relationship","/wiki/Antibiotic","/wiki/Antiviral_drug","/wiki/Chemotherapy","/wiki/Antibiotic","/wiki/Antiviral_drug","/wiki/Chemotherapy","/wiki/Drug_resistance","/wiki/Methicillin-resistant_Staphylococcus_aureus","/wiki/World_Health_Organization","/wiki/Centers_for_Disease_Control_and_Prevention","/wiki/Intravenous","/wiki/Vancomycin-resistant_Staphylococcus_aureus","/wiki/Linezolid","/wiki/Adverse_drug_reaction","/wiki/Cisapride","#cite_note-1","/w/index.php?title=Drug_of_last_resort&action=edit&section=1","/w/index.php?title=Drug_of_last_resort&veaction=edit&section=1","/wiki/Amikacin","/wiki/Cisapride","/wiki/Clozapine","#cite_note-2","/wiki/Colistin","/wiki/Imipenem","/wiki/Linezolid","/wiki/Levosimendan","/wiki/Milrinone","/wiki/Thalidomide","/wiki/Tolcapone","/wiki/Vancomycin","/wiki/Vigabatrin","/w/index.php?title=Drug_of_last_resort&action=edit&section=2","/w/index.php?title=Drug_of_last_resort&veaction=edit&section=2","#cite_ref-1","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1173548","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1173548","#cite_ref-2","http://www.ncbi.nlm.nih.gov/pubmed/12844323","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Drug_of_last_resort&oldid=566909334","/wiki/Help:Category","/wiki/Category:Medicine","/wiki/Category:Articles_needing_expert_attention_with_no_reason_or_talk_parameter","/wiki/Category:Articles_needing_expert_attention_from_July_2012","/wiki/Category:All_articles_needing_expert_attention","/wiki/Category:Pharmacology_articles_needing_expert_attention","/wiki/Category:Miscellaneous_articles_needing_expert_attention","/wiki/Category:Wikipedia_articles_needing_copy_edit_from_May_2013","/wiki/Category:All_articles_needing_copy_edit","/wiki/Category:Articles_with_weasel_words_from_May_2013","/w/index.php?title=Special:UserLogin&returnto=Drug+of+last+resort&type=signup","/w/index.php?title=Special:UserLogin&returnto=Drug+of+last+resort","/wiki/Drug_of_last_resort","/wiki/Talk:Drug_of_last_resort","#","/wiki/Drug_of_last_resort","/w/index.php?title=Drug_of_last_resort&action=edit","/w/index.php?title=Drug_of_last_resort&veaction=edit","/w/index.php?title=Drug_of_last_resort&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Drug_of_last_resort","/wiki/Special:RecentChangesLinked/Drug_of_last_resort","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Drug_of_last_resort&oldid=566909334","/w/index.php?title=Drug_of_last_resort&action=info","//www.wikidata.org/wiki/Q122435","/w/index.php?title=Special:Cite&page=Drug_of_last_resort&id=566909334","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Drug+of+last+resort","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Drug+of+last+resort&oldid=566909334&writer=rl","/w/index.php?title=Drug_of_last_resort&printable=yes","//ar.wikipedia.org/wiki/%D8%AF%D9%88%D8%A7%D8%A1_%D8%A7%D9%84%D9%85%D9%84%D8%A7%D8%B0_%D8%A7%D9%84%D8%A3%D8%AE%D9%8A%D8%B1","//de.wikipedia.org/wiki/Reserveantibiotikum","#","//www.wikidata.org/wiki/Q122435#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Drug_of_last_resort","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Medicine"],"headings":["Examples","References"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/commons/thumb/5/52/Acap.svg/36px-Acap.svg.png","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Sepsis","Septic_shock","Dose-response_relationship","Antibiotic","Antiviral_drug","Chemotherapy","Antibiotic","Antiviral_drug","Chemotherapy","Drug_resistance","Methicillin-resistant_Staphylococcus_aureus","World_Health_Organization","Centers_for_Disease_Control_and_Prevention","Intravenous","Vancomycin-resistant_Staphylococcus_aureus","Linezolid","Adverse_drug_reaction","Cisapride","Amikacin","Cisapride","Clozapine","Colistin","Imipenem","Linezolid","Levosimendan","Milrinone","Thalidomide","Tolcapone","Vancomycin","Vigabatrin"]}